Search results
Jun 12, 2023 · Dabigatran is used to treat blood clots deep in the body ( deep vein thrombosis, DVT) and lungs ( pulmonary embolism, PE) in adults who have received blood thinners by injection for 5 to 10 days.
Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [6] [7] Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. [6]
CrCl >30 mL/min: 110 mg PO 1-4 hr after surgery and after hemostasis has been achieved on first day, then 220 mg taken qDay for 28-35 days. If dabigatran is not started on the day of surgery,...
Oral. Prophylaxis of stroke in non-valvular atrial fibrillation, Prophylaxis of systemic embolism in non-valvular atrial fibrillation. Adult: 150 mg bid. Dose discontinuation may be required when switching to and from dabigatran or based on patient safety and tolerability (refer to detailed product guideline).
Dabigatran works by preventing blood clots from forming in the body. Pradaxa is used to treat blood clots deep in the body ( deep vein thrombosis, DVT) and lungs ( pulmonary embolism, PE) in adults who have received blood thinners by injection for 5 to 10 days.
Dabigatran will help prevent strokes and blood clots only as long as you continue to take it. Continue to take dabigatran even if you feel well. Make sure to refill your prescription before you run out of medication so that you will not miss doses of dabigatran.
DABIGATRAN (DA bi GAT ran) is an anticoagulant (blood thinner). It is used to lower the chance of stroke in people with a medical condition called atrial fibrillation. It is also used to treat or prevent blood clots in the lungs or in the veins.
Dec 12, 2021 · Dabigatran in cardiovascular disease management: A comprehensive review. Dabigatran, a direct thrombin inhibitor, has robust data for the treatment of deep venous thrombosis and pulmonary embolism, stroke prevention in non-valvular atrial fibrillation, and the prophylaxis of venous thromboembolism (VTE) after knee and hip replacement.
Dabigatran is used to decrease the risk of stroke and blood clots in patients with a serious heart rhythm problem called nonvalvular atrial fibrillation. Dabigatran is also used to treat and prevent blood clots (eg, deep vein thrombosis, pulmonary embolism) from occurring again in patients who already have received other medicines.
View dabigatran etexilate information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, contra-indications and monitoring requirements.
